{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:52:58Z","timestamp":1770677578131,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"abstract":"<jats:p>Wound complications in spine surgeries are common and serious. This study aimed to determine the risk of wound dehiscence with a low-dose of intrawound vancomycin compared to that with a high-dose and no-vancomycin and its effectiveness in the prevention of surgical site infection. Patients were categorized into 3 groups. The first group did not receive any intrawound vancomycin. In the second, patients received a high-dose of vancomycin (1\u2009g). The third group included patients who received a low-dose of intrawound vancomycin (250\u2009mg). Patient demographics, clinical data, and surgical data were also collected. Multivariate linear regression analysis was used to examine factors associated with dehiscence or infection. Of the 391 patients included in our study, 56 (14.3%) received a high-dose of intrawound vancomycin, 126 (32.2%) received a low-dose, and 209 (53.5%) did not receive any treatment. The overall incidence of wound dehiscence was 6.14% (24 out of 391 patients). Wound dehiscence was significantly higher (<jats:italic toggle=\"yes\">P<\/jats:italic> = .039) in the high-dose vancomycin group than in the low-dose vancomycin group. The overall incidence of postoperative infection was 2.05% (8 patients) and no statistically significant differences were observed between the low-dose and high-dose vancomycin groups. Patients with higher body mass index were more likely to experience wound dehiscence and postoperative infection, irrespective of the dose of vancomycin used. The use of low-dose intrawound vancomycin (250\u2009mg) resulted in less wound dehiscence compared with high-dose vancomycin. Further trials are required to evaluate the effectiveness of the low-dose in preventing postoperative infections.<\/jats:p>","DOI":"10.1097\/md.0000000000033369","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T14:06:25Z","timestamp":1681481185000},"page":"e33369","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Intrawound low-dose vancomycin is superior to high-dose in controlling the risk of wound dehiscence in spine surgeries"],"prefix":"10.1097","volume":"102","author":[{"given":"Ahmed M.","family":"Sonbol","sequence":"first","affiliation":[{"name":"Musculoskeletal Center of Excellence, International Medical Center, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-0241","authenticated-orcid":false,"given":"Ayman M.","family":"Baabdullah","sequence":"additional","affiliation":[{"name":"Musculoskeletal Center of Excellence, International Medical Center, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Awad A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Musculoskeletal Center of Excellence, International Medical Center, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid N.","family":"Kassab","sequence":"additional","affiliation":[{"name":"Musculoskeletal Center of Excellence, International Medical Center, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00264-011-1426-0","article-title":"Infections in spinal instrumentation.","volume":"36","author":"Gerometta","year":"2012","journal-title":"Int Orthop"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3171\/2014.8.SPINE1445","article-title":"A meta-analysis of spinal surgical site infection and vancomycin powder.","volume":"21","author":"Khan","year":"2014","journal-title":"J Neurosurg Spine"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/BRS.0000000000000496","article-title":"Medicaid status is associated with higher surgical site infection rates after spine surgery.","volume":"39","author":"Manoso","year":"2014","journal-title":"Spine"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/foc.2003.15.3.14","article-title":"Postoperative wound infections of the spine.","volume":"15","author":"Beiner","year":"2003","journal-title":"Neurosurg Focus"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/BRS.0b013e31819a827c","article-title":"Clinical outcomes of deep wound infection after instrumented posterior spinal fusion: a matched cohort analysis.","volume":"34","author":"Mok","year":"2009","journal-title":"Spine"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jocn.2019.07.025","article-title":"Cost and quality of life outcome analyses of postoperative infections after posterior lumbar decompression and fusion.","volume":"68","author":"Pennington","year":"2019","journal-title":"J Clin Neurosci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/sur.2015.146","article-title":"Intra-wound antibiotics and infection in spine fusion surgery: a report from Washington State\u2019s SCOAP-CERTAIN collaborative.","volume":"17","author":"Ehlers","year":"2016","journal-title":"Surg Infect (Larchmt)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/sur.2016.183","article-title":"Risk and protective factors associated with surgical infections among spine patients.","volume":"18","author":"Blood","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2018.10.FOCUS18470","article-title":"The effect of prophylactic vancomycin powder on infections following spinal surgeries: a systematic review.","volume":"46","author":"Dodson","year":"2019","journal-title":"Neurosurg Focus"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/TCRM.S185296","article-title":"Effect of intrawound vancomycin application in spinal surgery on the incidence of surgical site infection: a meta-analysis.","volume":"14","author":"Tailaiti","year":"2018","journal-title":"Ther Clin Risk Manage"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2192568218786252","article-title":"Intrawound treatment for prevention of surgical site infections in instrumented spinal surgery: a systematic comparative effectiveness review and meta-analysis.","volume":"9","author":"Lemans","year":"2019","journal-title":"Global Spine J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2015.7.FOCUS15258","article-title":"Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review.","volume":"39","author":"Ghobrial","year":"2015","journal-title":"Neurosurg Focus"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00590-016-1878-4","article-title":"A review of the application of vancomycin powder to posterior spinal fusion wounds with a focus on side effects and infection. A prospective study.","volume":"27","author":"Murphy","year":"2017","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.wneu.2014.12.033","article-title":"The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence.","volume":"83","author":"Bakhsheshian","year":"2015","journal-title":"World Neurosurg"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0034-1386754","article-title":"Sterile seroma resulting from multilevel XLIF procedure as possible adverse effect of prophylactic vancomycin powder: a case report.","volume":"5","author":"Youssef","year":"2014","journal-title":"Evid Based Spine Care J"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.wneu.2018.11.135","article-title":"Surgical protocol for infections, nonhealing wound prophylaxis, and analgesia: development and implementation of posterior spinal fusions.","volume":"123","author":"Belykh","year":"2019","journal-title":"World Neurosurg"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00586-015-3943-9","article-title":"Does intrawound application of vancomycin influence bone healing in spinal surgery?","volume":"25","author":"Eder","year":"2016","journal-title":"Eur Spine J"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4184\/asj.2018.12.1.162","article-title":"Do dose-dependent microbial changes occur during spine surgery as a result of applying intrawound vancomycin powder? A systematic literature review.","volume":"12","author":"Xie","year":"2018","journal-title":"Asian Spine J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/neuros\/nyy288","article-title":"Impact of powdered vancomycin on preventing surgical site infections in neurosurgery: a systematic review and meta-analysis.","volume":"84","author":"Texakalidis","year":"2019","journal-title":"Neurosurgery"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4103\/ajns.AJNS_294_17","article-title":"Comparison between 1\u2009g and 2\u2009g of intrawound vancomycin powder application for prophylaxis in posterior instrumented thoracic or lumbosacral spine surgery: a preliminary report.","volume":"14","author":"Kunakornsawat","year":"2019","journal-title":"Asian J Neurosurg"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/neuros\/nyw097","article-title":"Does intrawound vancomycin application during spine surgery create vancomycin-resistant organism?","volume":"80","author":"Chotai","year":"2017","journal-title":"Neurosurgery"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.spinee.2019.01.002","article-title":"Selection pressures of vancomycin powder use in spine surgery: a meta-analysis.","volume":"19","author":"Gande","year":"2019","journal-title":"Spine J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2106\/JBJS.17.00459","article-title":"Does vancomycin powder decrease surgical site infections in growing spine surgery? A preliminary study.","volume":"100","author":"Thompson","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/BRS.0000000000001710","article-title":"Is intraoperative local vancomycin powder the answer to surgical site infections in spine surgery?","volume":"42","author":"Hey","year":"2017","journal-title":"Spine"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BRS.0000000000001371","article-title":"Intrawound vancomycin decreases the risk of surgical site infection after posterior spine surgery: a multicenter analysis.","volume":"43","author":"Devin","year":"2018","journal-title":"Spine"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/BRS.0000000000000789","article-title":"Reducing surgical site infection in spinal surgery with betadine irrigation and intrawound vancomycin powder.","volume":"40","author":"Tomov","year":"2015","journal-title":"Spine"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/BRS.0000000000000465","article-title":"Safety of topical vancomycin for pediatric spinal deformity: nontoxic serum levels with supratherapeutic drain levels.","volume":"39","author":"Armaghani","year":"2014","journal-title":"Spine"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BRS.0000000000000241","article-title":"Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends.","volume":"39","author":"Ghobrial","year":"2014","journal-title":"Spine"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jor.2018.01.032","article-title":"Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: an in vitro study.","volume":"15","author":"Liu","year":"2018","journal-title":"J Orthopaedics"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"250","DOI":"10.12659\/MSMBR.902879","article-title":"Vascular graft impregnation with antibiotics: the influence of high concentrations of rifampin, vancomycin, daptomycin, and bacteriophage endolysin HY-133 on viability of vascular cells.","volume":"23","author":"Herten","year":"2017","journal-title":"Med Sci Monit Basic Res"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3171\/2016.3.SPINE151491","article-title":"The effect of vancomycin powder on human dural fibroblast culture and its implications for dural repair during spine surgery.","volume":"25","author":"Goldschmidt","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1071100718766655","article-title":"Impact of vancomycin treatment on human mesenchymal stromal cells during osteogenic differentiation.","volume":"39","author":"Bariteau","year":"2018","journal-title":"Foot Ankle Int"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/BRS.0000000000001712","article-title":"The effect of vancomycin and gentamicin antibiotics on human osteoblast proliferation, metabolic function, and bone mineralization.","volume":"42","author":"Philp","year":"2017","journal-title":"Spine"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3171\/2015.11.SPINE15536","article-title":"The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.","volume":"25","author":"Mendoza","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jor.21343","article-title":"Effect of various concentrations of antibiotics on osteogenic cell viability and activity.","volume":"29","author":"Rathbone","year":"2011","journal-title":"J Orthop Res"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1097\/BSD.0000000000000045","article-title":"Intrawound vancomycin powder decreases staphylococcal surgical site infections after posterior instrumented spinal arthrodesis.","volume":"28","author":"Heller","year":"2015","journal-title":"J Spinal Disord Tech"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/BRS.0000000000001133","article-title":"Comparison of Intrawound vancomycin utility in posterior instrumented spine surgeries between patients with tumor and nontumor patients.","volume":"40","author":"Liu","year":"2015","journal-title":"Spine"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1302\/1863-2548.11.170107","article-title":"Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare.","volume":"11","author":"DeFrancesco","year":"2017","journal-title":"J Child Orthop"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/os.12356","article-title":"Effect of intra-wound vancomycin for spinal surgery: a systematic review and meta-analysis.","volume":"9","author":"Xie","year":"2017","journal-title":"Orthop Surg"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3171\/2017.2.SPINE161310","article-title":"Prophylactic use of intraoperative vancomycin powder and postoperative infection: an analysis of microbiological patterns in 1200 consecutive surgical cases.","volume":"27","author":"Adogwa","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.spinee.2013.11.047","article-title":"Obese class III patients at significantly greater risk of multiple complications after lumbar surgery: an analysis of 10,387 patients in the ACS NSQIP database.","volume":"14","author":"Buerba","year":"2014","journal-title":"Spine J"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/BRS.0000000000003084","article-title":"The impact of body mass index (BMI) on 30-day outcomes following posterior spinal fusion in neuromuscular scoliosis.","volume":"44","author":"Malik","year":"2019","journal-title":"Spine"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/2192568218771363","article-title":"Risk factors for perioperative complications in morbidly obese patients undergoing elective posterior lumbar fusion.","volume":"8","author":"Ranson","year":"2018","journal-title":"Global Spine J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:39:37Z","timestamp":1746326377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":43,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033369","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}